Last Price | 74.10 | Max Price | 110.30 |
Min Price | 74.10 | 1 Year return | 17.99 |
Avg. Target | 114.84 | Expected Return | 54.98 % |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Sell | 0 | Rating | |
Hold | 1 | Concensus | |
Buy | 8 | ||
Annual report 2016 |
Contact info:Street: Benrather Strasse 18-20Zip Code: 40214City: DuesseldorfCountry: GermanyPhone: 49 211 6181 -00Email: info@gerresheimer.comWebsite: www.gerresheimer.comCEO: Uwe RöhrhoffCFO: Rainer Beaujean
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 1,392 | 2,019,579 | 0.07 % |
2020 | 1,419 | 2,170,517 | 0.07 % |
2021 | 1,498 | 2,404,876 | 0.06 % |
2022 | 1,817 | 2,645,792 | 0.07 % |
2023 | 0 | 0 | 0.00 % |
Analysts expect over 2021 rising revenue Gerresheimer
Analysts expect over 2021 rising revenue Gerresheimer
Analysts expect revenue increase Gerresheimer
Analysts foresee more revenue Gerresheimer
Analysts: more sales Gerresheimer
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Gerresheimer 's headquarter is located in Duesseldorf. The company mostly operates in the health care eq. & services sector. Uwe R�hrhoff is operating by ' CEO. Rainer Beaujean is financially responsible for the company as CFO. The global health care companies gained over the past 10 years on average 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.
The stock lost over the past 12 months at around 0 percent. Over the period from December 2011 till December 2016 the stock rose on average 123 percent. Gerresheimer 's revenues between 2011 and 2015 were relatively steady and moved between 1,22 billion euros and 1,38 billion euros. The net results between 2011 and 2015 were far from constant and fluctuated between 54,43 million euros and 112,66 million euros.
Over the past 5 years the German company paid out dividends. Over the past 5 years Gerresheimer 's dividend yield was at around 3,55 percent per year. In the period 2011 till 2015 Gerresheimer paid it's investors each year a higher dividend per share. So we could call Gerresheimer a kind of dividend aristocrat.
At the end of 2015 the company had around 11,1 thousand people employed.
At the end of 2015 the German company had a balance sheet of 2,42 billion euros. At the end of 2015 the total debt positon equaled 1,79 billion euros. This is around 74,11 percent of the total balance sheet. Last year the health care company's price/earnings-ratio (PE) was around 18. So the investors valued the stock at 18 times 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the German stock can be seen as a value stock.
The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 2,21 billion euros. At the end of 2015 the German company had around 31,4 million stocks listed.
All the annual reports of Gerresheimer are available here. More information about Gerresheimer can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
1,377
|
1,375
|
1,348
|
1,368
|
1,392
|
1,419
|
Costs |
1,273
|
1,254
|
1,247
|
1,239
|
1,311
|
1,330
|
Profit |
104
|
122
|
101
|
129
|
81
|
89
|
Margin of profit |
7.57
|
8.84
|
7.48
|
9.43
|
5.80
|
6.24
|
ROI |
16.64
|
16.75
|
13.40
|
14.78
|
8.73
|
10.02
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
626
|
726
|
753
|
873
|
925
|
884
|
Debt |
1,793
|
1,648
|
1,691
|
1,858
|
1,716
|
1,733
|
Total assets |
2,419
|
2,374
|
2,444
|
2,731
|
2,641
|
2,617
|
Solvency |
25.89
|
30.58
|
30.81
|
31.95
|
35.03
|
33.78
|
Cash |
94
|
118
|
287
|
81
|
86
|
88
|
Cashflow |
204
|
173
|
219
|
173
|
193
|
222
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.11
|
0.11
|
0.13
|
0.09
|
0.11
|
0.13
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
72.19
|
70.62
|
69.12
|
57.25
|
69.00
|
Eps |
3.87
|
3.21
|
4.11
|
2.57
|
2.82
|
Price/earnings-ratio |
18.65
|
22.00
|
16.82
|
22.28
|
26.28
|
Dividend |
1.05
|
1.10
|
1.15
|
1.20
|
1.25
|
Dividend % |
1.45 %
|
1.56 %
|
1.66 %
|
2.10 %
|
1.69 %
|
Payout % |
0.27
|
0.34
|
0.28
|
0.47
|
0.44
|
Book value |
23.13
|
23.98
|
27.79
|
29.46
|
28.15
|
Market to book |
0.32
|
0.34
|
0.40
|
0.51
|
0.38
|
Cashflow per stock |
5.53
|
6.98
|
5.52
|
6.14
|
7.08
|
Stocks |
31
|
31
|
31
|
31
|
31
|
Market Cap |
2.266.77
|
2.217.47
|
2.170.37
|
1.797.65
|
2.326.74
|
Date
|
Price
|
---|---|
29 Nov 2024
|
74.10
|
27 Nov 2024
|
75.20
|
13 Nov 2024
|
74.85
|
08 Nov 2024
|
75.95
|
05 Nov 2024
|
78.65
|
31 Oct 2024
|
79.70
|
29 Oct 2024
|
83.05
|
23 Oct 2024
|
82.75
|
19 Oct 2024
|
84.85
|
16 Oct 2024
|
82.75
|
14 Oct 2024
|
82.45
|
05 Oct 2024
|
79.10
|
02 Oct 2024
|
79.40
|
27 Sep 2024
|
96.90
|
20 Sep 2024
|
101.80
|
17 Sep 2024
|
99.75
|
13 Sep 2024
|
103.00
|
28 Aug 2024
|
94.60
|
26 Aug 2024
|
95.45
|
23 Aug 2024
|
97.35
|
11 Aug 2024
|
98.75
|
07 Aug 2024
|
97.00
|
05 Aug 2024
|
91.65
|
01 Aug 2024
|
95.75
|
30 Jul 2024
|
95.55
|
26 Jul 2024
|
92.40
|
23 Jul 2024
|
96.45
|
16 Jul 2024
|
100.70
|
10 Jul 2024
|
103.00
|
09 Jul 2024
|
101.00
|